Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Clinical trial NCT04537156 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04537156
- Sponsor
- Xiamen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-05
- Primary completion
- 2027-12-31
- Enrollment
- 9327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.